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Abstract
Background: Caloric restriction (CR) can increase longevity in rodents and improve memory function in humans.
α-Lipoic acid (LA) has been shown to improve memory function in rats, but not longevity. While studies have
looked at survival in rodents after switching from one diet to another, the underlying mechanisms of the beneficial
effects of CR and LA supplementation are unknown. Here, we use RNA-seq in cerebral cortex from rats subjected to CR
and LA-supplemented rats to understand how changes in diet can affect aging, neurodegeneration and longevity.
Results: Gene expression changes during aging in ad libitum-fed rats are largely prevented by CR, and neuroprotective
genes are overexpressed in response to both CR and LA diets with a strong overlap of differentially expressed
genes between the two diets. Moreover, a number of genes are differentially expressed specifically in rat cohorts
exhibiting diet-induced life extension. Finally, we observe that LA supplementation inhibits histone deacetylase
(HDAC) protein activity in vitro in rat astrocytes. We find a single microRNA, miR-98-3p, that is overexpressed
during CR feeding and LA dietary supplementation; this microRNA alters HDAC and histone acetyltransferase
(HAT) activity, which suggests a role for HAT/HDAC homeostasis in neuroprotection.
Conclusions: This study presents extensive data on the effects of diet and aging on the cerebral cortex transcriptome,
and also emphasises the importance of epigenetics and post-translational modifications in longevity and neuroprotection.
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Background
Ageing is arguably the major biomedical challenge of the
21st century with the incidence of age-related diseases,
and neurodegenerative diseases in particular, expected to
increase dramatically in the coming decades. Brain ageing
frequently underlies cognitive decline and is a major risk
factor for neurodegenerative conditions such as Alzheimer's
disease (AD) and Parkinson's disease. Mental health is also
a major concern of ageing adults. The exact molecular
mechanisms underlying brain ageing, however, remain
unknown [1].
A major tool available to researchers studying ageing
is caloric restriction (CR), which consists of restricting
food intake (without malnutrition) of organisms normally
fed ad libitum (AL). CR is the only dietary intervention
known to increase longevity and retard the process of age-
ing in several model organisms. In mice and rats, CR can
increase longevity by ~30 %, delay physiological ageing
and postpone or diminish the morbidity of most age-
related diseases [2]. CR can also delay brain iron accumu-
lation, preserving motor performance, and in one study
increased survival in rhesus monkeys [3, 4]. However, as
reported for rodent species [5, 6], there is significant vari-
ation in the mortality effects of CR feeding in different
studies using rhesus monkeys [7, 8]. In elderly humans,
CR has been shown to improve memory function [9].
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α-Lipoic acid (LA) is an anti-oxidant which naturally
occurs in many foods. It does not increase survival in ro-
dent studies [10], but rats supplemented with LA during
the AL phase of feeding when switched from CR to AL
feeding at 12 months of age retained the extended longev-
ity characteristic of CR feeding throughout life despite a
return to AL feeding. This was termed a dietary memory
effect [10]. These animals gained weight, indicating that
although the longevity effects of CR were preserved, other
effects of CR feeding were not. Conversely, animals
switching from AL, with a diet supplemented with LA, to
CR feeding without LA supplementation did not exhibit
extended longevity, yet extended survival is a normal
response of this feeding switch when LA is not in-
cluded in the diet during AL feeding. This LA-induced
memory effect gives us a unique opportunity to identify
the mechanisms by which CR retards ageing and in-
creases longevity without the confounding physiological
effects of CR (e.g. restricted growth). Furthermore, LA
can compensate for age-related, long-term memory def-
icits in old rats [11] and improve memory and learning in
prematurely aged mice [12].
The underlying mechanisms of the beneficial effects of
CR and LA supplementation are unknown. Understanding
how these changes in diet and feeding regime can affect
ageing, neurodegeneration and longevity is of great im-
portance and could pinpoint key genes and pathways
for further research relevant to human application [13].
The aim of this work was to study the transcriptomes,
using RNA-seq, of the cerebral cortex of rats subjected
to CR and LA-supplemented rats and compare them
with animals maintained on an AL diet not supplemented
with LA.
Using rat cerebral cortex from a previous study [10],
which identified the dietary memory effect, our results
show changes in expression of genes related to secretory
and neuroendocrine pathways with ageing in AL-fed
rats, many of which are prevented by CR. We find also
that CR and LA supplementation share a largely com-
mon gene expression profile, despite the different effects
on longevity. These shared genes are mainly neuropro-
tective and may act through prevention of excitoxicity,
by down-regulation of glutamate receptors and calcium
kinases, and inducing protection against oxidative stress
by the up-regulation of glutathione S-transferases (GSTs)
and thioredoxin. We also propose that this neuroprotec-
tive effect of CR and LA is driven by changes in histone
deacetylase (HDAC) and histone acetyltransferase (HAT)
homeostasis and implicate a miRNA (miR-98-3p) in this
process. This was demonstrated using transfection, cell
culture and HDAC/HAT activity assays. We show that
genes involved in acetylation of histones are altered and
may be important in the dietary memory effect of LA on
longevity. Finally, we identify 137 genes that are associated
with rat cohorts exhibiting diet-induced longevity. Many
of these are evolutionarily conserved in mouse, worm and
fly longevity networks.
Results
Using tissues from a previous study [10], we performed
RNA-seq on the cerebral cortex of rats. Three basic
feeding/dietary groups were established: rats fed AL
throughout life; rats subjected to CR throughout life; or
rats fed a LA-supplemented diet during the AL feeding
phase before switching to or from CR feeding at 12 months
of age. The longevity of each of these groups of animals
and the number of differentially expressed (DE) genes
are shown in Table 1. To establish the effect of ageing
on the transcriptome and the impact of CR on age-related
changes, rats were sampled at 6, 12 and 28 months of age.
Changes observed in the ageing transcriptome are
prevented by a calorie restricted diet in rats
We have previously published an analysis of whole tran-
scriptome RNA-seq for an AL-fed ageing cohort (6, 12
and 28 months) [14]. In the current study we re-
sequenced the AL-fed ageing cohort at a greater depth
on the 5500XL SOLiD system (previously we used the
SOLiD system v4), along with all the other experimental
groups in this study to eliminate any platform bias. The
major findings from the previous analysis were con-
firmed and the number of DE genes was similar, show-
ing good replication (data not shown), but due to the
updated annotation of the rat genome we found also a
number of new DE genes.
Our new analysis emphasises an enrichment amongst
DE genes with age for antigen presentation via MHC II
(Fig. 1a; Additional file 1) and the down-regulation of heat
shock proteins, as previously described [14]. However, sta-
tistically significant enrichment for synaptic vesicle cycle
and vesicular transport related genes are also observed
Table 1 Mean survival of rats on the various diets used in this
study and the number of DE genes compared with AL feeding
Rat cohortsa Mean survival
(days) from [10]
SE (days) Number of DE genes
compared with AL
AL 854 22 NA
*AL > CR 1000 33 1028
AL + LA > CR 859 57 986
*CR 1025 25 941
CR > AL 914 44 1435
*CR > AL + LA 1009 34 1233
AL + LA 858 27 1003
aDiet switches are indicated by “>” and occurred at 12 months of age.
Asterisks (*) indicate long-lived cohorts, all statistically significant versus AL.
Benjamini-Hochberg false discovery rate <0.05; n = 6 per group (pooled two
by two) for the RNA-seq; 10,620 genes expressed in total. NA not applicable,
SE standard error
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(Fig. 1a). Chromogranin B, which is important in secretion
and neuroendocrine pathways, is down-regulated with age
(6 versus 28 months and 12 versus 28 months), which is
interesting as this gene is also down-regulated in AD [15].
Conversely, long-lived Snell’s dwarf mice show higher
levels of chromogranin B [16]. Pcsk1n, an inhibitor of
Pcsk1, which regulates the proteolytic cleavage of neuro-
endocrine peptide precursors, including chromogranin B
[17], is under-expressed with age (12 versus 28 months).
Moreover, down-regulation of genes related to synaptic
transmission and synaptic vesicle transport (syntaxin-1b,
syntaxin-binding protein 1, syntaxin-1A and Napb), post-
synaptic signalling modulators (e.g. Syngap1, Shank1,
Homer2 and Shank3) and a glutamate receptor (Grik4)
occurs with age (6 versus 28 months) in the AL cohort.
These distinct changes in secretory pathways, synaptic
vesicle transport and synaptic transmission are consistent
with observations of neurodegenerative diseases [18–20].
Rev-erb-α (nuclear receptor 1D1) is a transcriptional
repressor involved in circadian rhythmicity (an enriched
term; Fig. 1a) and metabolism, which is down-regulated
with age. Its mode of action is through the recruitment
of the co-repressor NCoR, which is also down-regulated
in our data, and activation of Hdac3 [21]. Nur77 (nuclear
receptor 4A1), a transcription factor that is down-regulated,
interacts with HAT, p300 and Hdac1, which regulates
expression through acetylation [22]. These results are
interesting because nuclear receptors are important in
hormone homeostasis, sensing hormones and regulating
the downstream expression of multiple genes through epi-
genetic mechanisms. All genes DE with age are presented
in Additional file 2.
The majority of the gene expression changes observed
with age in AL-fed rats are not present during ageing of
CR rats (Fig. 1b), with the exception of Hspa1b (heat
shock protein, −1.8 fold change (FC) in CR and −3.6 FC
in AL groups), supporting the hypothesis that the ageing
process is retarded by CR. Fewer genes are DE with age
in CR than in AL (Table 2) and there are a limited num-
ber of genes which are only DE during ageing in rats
subjected to CR (Fig. 1b).
Over-representation analysis (gene set enrichment
analysis (GSEA), Molecular Signatures Database, Broad
Institute) independently revealed that our data statistically
significantly overlapped with a previous meta-analysis of
ageing based on microarray studies (false discovery rate
(FDR) q value = 2.12 × 10-7) [23] and with a list of genes
DE after methyl binding protein knockdown (MeCP2,
MB1 and MBD2) in Hela cells (1.8 × 10-4) [24]. This leads
to the question: what is driving this altered gene expres-
sion profile with age?
The histone H3 methyltransferase Dot1L was down-
regulated with age in the AL cohort (−1.2 log FC in
6 months AL versus 28 months AL; −1.4 FC in 12 months
AL versus 28 months AL). Previously, H3K79 methylation
(regulated by DOT1L) was identified as a novel histone
marker for ageing and cancer [25]. Tet3, an important
regulator of DNA demethylation and H3K4 trimethylation
[26–28], is down-regulated with age in our data (−1.2 FC
in 12 months AL versus 28 months AL). Furthermore, the
chromatin remodeller Chd5 (Chromodomain helicase
DNA binding protein 5) was DE with age in our results
and has previously been linked to ageing and AD [29].
Taken together, these results indicate that there are
changes in the responsiveness of cells to hormonal signal-
ling with age, as well as expression changes in genes re-
lated to chromatin remodelling and modification, possibly
affecting transcription at various levels.
Neuroprotective genes are overexpressed in rats in
response to CR and LA-supplemented diets
In order to understand the previously observed neuro-
protective effects of CR and LA [3, 4, 9, 11, 12, 30], we
focused on the response of rats to CR and LA-
supplemented diets at 28 months of age. By directly
comparing 28 months AL to 28 months CR, we found
895 DE genes enriched for glutamatergic synapse,
(See figure on previous page.)
Fig. 1 Age-related differential gene expression in rats fed AL and subjected to CR. a Two simplified networks of related, statistically significant
enriched Gene Ontology (GO) terms using the Cytoscape add-on ClueGO [30, 31]. The network comparing 6 months AL (6 m AL) and 28 months
AL (28 m AL) is shown on the left and 12 months AL (12 m AL) and 28 months AL (28 m AL) is shown on the right. DE genes were used to generate a
GO term network. The filled coloured circles (nodes) represent each statistically significant parent GO term. The lines (edges) between the nodes show
that there are overlapping genes between terms. The Cytoscape add-on ClueGO allows enrichment analysis and the collapsing of GO terms into parent
categories for each comparison. Each of the terms is statistically significant (Benjamini-Hochberg correction <0.05). Colours represent shared GO terms.
The different sizes of the nodes relate to how many genes fall into the terms. b Heatmap of the DE genes with age across all AL and CR datasets
(Table 2); created in R using the heatmap3 package. The y-axis represents all the DE genes. Red = up-regulated, blue = down-regulated, log2
fold change reported for statistically significant DE genes. White means no statistically significant change in expression. 6 m = 6 months of
age, 12 m = 12 months of age, 28 m = 28 months of age
Table 2 Comparison of the number of genes differentially
expressed with age in AL and CR groups
Comparison AL CR
6 versus 12 months 24 (15 protein coding) 10 (10 protein coding)
6 versus 28 months 180 (162 protein coding) 17 (17 protein coding)
12 versus 28 months 174 (141 protein coding) 70 (45 protein coding)
Benjamini-Hochberg false discovery rate <0.05; n = 6 per group (pooled two
by two); 10,620 genes expressed in total
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oxidative phosphorylation and terpenoid backbone
biosynthesis (Additional file 3). Furthermore, there is a
71 % overlap between genes DE in CR rats and in LA-fed
rats at 28 months when compared with AL rats; this over-
lap is reduced to 49 % when including all the dietary varia-
tions in our study (Fig. 2b; Table 3; Additional file 4). By
taking the overlapping DE genes induced by CR feeding
and LA diets we generated an enrichment map based
on Gene Ontology (GO) terms. Neurotrophin signalling
pathway, essential in the survival of neurons through pro-
tection against excitotoxicity [31] and reported to change
in the aged brain [32], is a key enriched term (Fig. 2a). Fur-
thermore, neurotrophins protect neurons against excito-
toxicity and rescue oxidative stress-mediated apoptosis
by involvement of the phosphatidylinositol and
mitogen-activated protein kinase (MAPK) pathways
[33]. Using DAVID functional enrichment analysis we
found that the majority of the down-regulated genes
overlapping between CR feeding and LA diets are involved
in neuroprotection (Additional file 4). Glutamate recep-
tors and receptor activity genes were altered or enriched
in our datasets, and we conducted quantitative PCR
(qPCR) to confirm these findings (Fig. 2c).
Strong enrichment of oxidative phosphorylation (DA-
VID enrichment score (ES) = 5.44, FDR = 8.93 × 10-10) and
AD was found in the 490 shared up-regulated genes in CR
and LA diets (Fig. 2a; Additional file 4). GSTs are a family
of enzymes that play an important role in detoxification
and protect neurons from oxidative insult [34]. During CR
feeding and LA supplemented diets, four GSTs were up-
regulated (Gsta1, Gstm1, Gstp1, Gstt3). Furthermore, thior-
edoxins are redox proteins that respond to reactive oxygen
species, therefore acting as antioxidants, and three are up-
regulated in response to CR feeding and LA supple-
mentation (Txndc17, Txnip and Txnrd1). Oxidative
stress is thought to be important in ageing, in particu-
lar in energy-rich tissues such as the brain, promoting
degenerative disease and accelerating ageing [35];
therefore, up-regulation of antioxidant enzymes may be
neuroprotective. Overall, changes in synaptic transmis-
sion and susceptibility to glutamate excitotoxicity have
been described as a potential cause of neurodegenera-
tion [36]. Our results suggest that CR and LA feeding
induce gene expression changes that prevent excitotoxi-
city through down-regulation of glutamate receptors and
calcium kinases, and protect against oxidative stress, indu-
cing a neuroprotective profile.
We set out to identify the genes regulating this neuro-
protective profile and noticed that a large number of
chromatin-related and epigenetic regulators were altered
due to CR feeding and LA supplementation (Table 3).
This neuroprotective profile may be driven through
changes in epigenetic regulators altering the acetylation
and methylation status of DNA, histones and proteins.
However, there are a number of epigenetic regulators that
are DE specifically in response to either CR feeding or LA
supplementation, and we predicted that there would be a
shared regulator of this neuroprotective profile.
In order to identify candidates for this shared regulation
of the neuroprotective profile, we performed a further
small RNA-seq experiment (see “Materials and methods”)
to assay microRNAs (miRNAs) in our samples. We found
that each diet group elicits its own specific miRNA profile
(Fig. 3a), with switching from AL supplemented with LA
to CR at 12 months leading to the greatest number of DE
miRNAS (Table 4; for all DE miRNAs see Additional file
5). However, a single miRNA (miR-98-3p) was signifi-
cantly overexpressed in all groups of CR rats and/or rats
fed LA-supplemented diets (Fig. 3b). As mir-98 down-
regulation in the cerebellum has been associated with AD
and with neuroprotection [37, 38], we examined whether
this miRNA could regulate the neuroprotective profile
observed.
To consider this question and relate it to our neuro-
protective profile (Fig. 2a, c) induced by CR and LA diets,
we investigated the role of miR-98-3p in HAT/HDAC
homeostasis because changes in HAT/HDAC homeostasis
have been noted as a potential cause of neurodegeneration
[39]. Using CTX TNA2 cells (rat astrocytes derived from
the cerebral cortex), we transfected miR-98-3p inhibitors
and mimics, and measured HDAC and HAT activity
(Fig. 3c). LA-supplemented cells showed a strong inhib-
ition of HDAC activity as predicted from the structure of
LA [40]. Increasing miR-98-3p (using a mimic) did not
alter HDAC or HAT activity, suggesting that LA-induced
inhibition of HDAC activity is not elicited through mir-
98-3p. However, inhibition of miR-98-3p did up-regulate
HDAC activity and greatly inhibited HAT activity. These
results suggest that miR-98-3p is a candidate regulator
of the neuroprotective profile by maintaining the HAT/
HDAC balance and hence acetylation equilibrium.
Defining the dietary memory effect of LA on longevity
By far the most intriguing observation of Merry et al.
[10] was the fact that LA cannot increase longevity alone
but rats switching from CR to AL feeding supplemented
with LA at 12 months of age retained the extended lon-
gevity characteristic of CR, despite being on an AL diet.
Using our RNA-seq data we set out to disentangle the
dietary memory effect of LA. Table 1 shows the mean
survival of these rats on various feeding and dietary
combinations and the number of DE genes compared
with AL feeding. Figure 4a shows how we identified the
extended longevity effect of CR switching to AL with
LA. Briefly, we compared the lists of DE genes from the
various cohorts in order to remove the confounding ef-
fects of diet switching and LA supplementation without
extended longevity (Fig. 4a). This allowed us to focus on
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Fig. 2 CR and LA supplementation elicit a similar neuroprotective gene expression profile. a Simplified networks of related statistically significant
enriched GO terms using the Cytoscape add-on ClueGO [30, 31]. The network was made from the overlapping differentially expressed genes between
all diets with CR and LA supplementation (a.k.a neuroprotective profile; see text for details). The Cytoscape add-on ClueGO allows enrichment
analysis and the collapsing of GO terms into parent categories for each comparison. Each of the terms is statistically significant (Benjamini-Hochberg
correction <0.05). The filled coloured circles (nodes) represent each statistically significant enriched parent GO term. The lines (edges) between the nodes
show that there are overlapping genes within terms. The different sizes of the nodes relate to how many genes fall into the terms. b Heatmap of the
differentially expressed genes (Table 1) across all diets with CR and LA supplementation when compared with AL; created in R using the heatmap3
package. Red = up-regulated, blue = down-regulated, log2 FC reported for statistically significant DE genes. White means no statistically significant
change in expression. c Quantitative PCR confirmation of RNA-seq results, showing glutamate receptor differential expression (GRIN2c, GRM1 and GRID2)
when comparing CR (left) and AL supplemented with LA (right) with AL alone. Orange bars are RNA-seq FC and blue bars are qPCR FC. The horizontal
dotted line represents the one FC cutoff. The vertical dotted line separates the CR and LA supplemented comparisons. Error bars represent the standard
error calculated for log2 FC as follows: (Standard error/Mean) × log2e. Hprt1, B2m and Ywhaz were used as reference genes. N = 6 per group, unpooled
RNA from the RNA-seq experiment











ENSRNOG00000001442 Por NADPH–cytochrome P450 reductase
[Source:UniProtKB/Swiss-Prot;Acc:P00388]
1.24 8.58 × 10−06 0.75 1.19 × 10−02
ENSRNOG00000043098 Mt2A Metallothionein-2 [Source:UniProtKB/
Swiss-Prot;Acc:P04355]
1.06 7.02 × 10−04 1.30 4.81 × 10−05
ENSRNOG00000048961 Bhlhe41 Bhlhe41 1.06 5.45 × 10−04 0.92 7.17 × 10−03
ENSRNOG00000047374 Gnas GNAS isoform GNASL [Source:RefSeq
peptide;Acc:NP_062005]
0.99 2.69 × 10−08 0.90 1.73 × 10−05
ENSRNOG00000008001 Rab3b Ras-related protein Rab-3B
[Source:UniProtKB/Swiss-Prot;Acc:Q63941]
0.89 4.16 × 10−04 0.57 3.70 × 10−02
ENSRNOG00000018958 Mt3 Metallothionein-3 [Source:UniProtKB/Swiss-
Prot;Acc:P37361]
0.77 3.94 × 10−03 0.58 3.88 × 10−02
ENSRNOG00000005183 Rtf1 RNA polymerase-associated protein RTF1 homolog
[Source:RefSeq peptide;Acc:NP_001102428]
0.58 4.50 × 10−03 0.73 4.32 × 10−05
ENSRNOG00000006816 Urb5 Ubiquitin protein ligase E3 component
n-recognin 5 [Source:MGI Symbol;Acc:MGI:1918040]
−0.43 3.64 × 10−02 −0.44 2.97 × 10−02
ENSRNOG00000013837 Trp53bp1 Transformation related protein 53 binding
protein 1 [Source:MGI Symbol;Acc:MGI:1351320]
−0.50 1.48 × 10−02 −0.53 9.34 × 10−03
ENSRNOG00000005544 Kansl1 KAT8 regulatory NSL complex subunit 1
[Source:MGI Symbol;Acc:MGI:1923969]
−0.53 2.46 × 10−02 −0.61 1.26 × 10−02
ENSRNOG00000004289 Kdm6a Lysine (K)-specific demethylase 6A [Source:MGI
Symbol;Acc:MGI:1095419]
−0.59 1.24 × 10−02 −0.55 7.33 × 10−03
ENSRNOG00000003220 H3f3c Histone H3.3 [Source:UniProtKB/Swiss-
Prot;Acc:P84245]
−0.72 4.50 × 10−02 −0.75 1.50 × 10−02
ENSRNOG00000011523 H2afy Core histone macro-H2A.1 [Source:UniProtKB/
Swiss-Prot;Acc:Q02874]
−0.73 2.56 × 10−03 −0.82 5.60 × 10−04
ENSRNOG00000015781 Ndst3 Bifunctional heparan sulfate N-deacetylase/
N-sulfotransferase 3 [Source:RefSeq
peptide;Acc:NP_001178645]
−0.82 4.27 × 10−03 −0.77 8.10 × 10−03
ENSRNOG00000046636 HIST1H4B Histone H4 Osteogenic growth peptide −0.92 6.85 × 10−04 -1.27 8.54 × 10−08
ENSRNOG00000017714 Usp3 Ubiquitin carboxyl-terminal hydrolase 3
[Source:RefSeq peptide;Acc:NP_001020595]
−0.99 1.11 × 10−02 −0.99 1.37 × 10−02
ENSRNOG00000006689 Chd7 Chromodomain helicase DNA binding protein 7
[Source:MGI Symbol;Acc:MGI:2444748]
-1.09 3.92 × 10−03 −0.93 1.60 × 10−02
ENSRNOG00000014397 Zic2 zinc finger protein ZIC 2 [Source:RefSeq
peptide;Acc:NP_001101862]
-1.81 5.00 × 10−04 -2.06 7.44 × 10−05
Benjamini-Hochberg FDR <0.05; n = 6 per group (pooled two by two)
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the genes associated specifically with the dietary memory
effect (all DE genes are listed in Additional file 6). Dietary
memory effect genes were enriched for the GO terms neu-
rotrophin, insulin, phosphotidylinostol, NGF and GnRH
signalling (Fig. 4b).
Genes involved in epigenetic regulation and specific-
ally in the acetylation of histones are altered in the
LA-supplemented long-lived groups. Examples include
Nur77 (Nr4a1), which regulates gene expression through
acetylation [22], and Morf4l1 (mortality like factor 1),
which is involved in H2a and H4 acetylation and dea-
cetylation (Additional file 6). These results suggest
that histone acetylation is important in maintaining
the CR longevity profile through LA supplementation.
Further to this, other chromatin modifiers may play a
role in the dietary memory effect (e.g. Bag4, Mef2c
Hdac5, Bcorl1, H3f3b, Brd3, Kat6a, Hist1h1d and
Chmp1a).
Genes involved in post-translational modification
and metabolism of proteins are also enriched amongst
genes potentially involved in the dietary memory effect
(Fig. 4b). Examples include phosphatases/phosphorylases
(Pp1r16a, Pygb, Ppm1f, Camk1g, Dusp8, Dusp6 and
Dusp14 and a protein phosphatase inhibitor (Ppi2)) and
kinases (Pacsin1, Stk32c, Cdkn1a (a.k.a. p21, a major
player in cell senescence [41]), Sik1). This suggests that
changes in the activity of target proteins through post-
translational modification of non-histone proteins could
be an important effect of LA supplementation and may
play a role in its memory effect.
A previous study has noted a change in acetylation
status of mitochondrial proteins with CR feeding [42].
Therefore, we also assessed non-histone protein acetylation
using Western blotting (see “Materials and methods”).
In our study we observed changes in global lysine
acetylation status of proteins in the liver but not in
the brain (Additional file 7). This suggests that post-
translational modification of non-histone proteins may
(See figure on previous page.)
Fig. 3 Each diet group and age elicits its own miRNA expression profile but miR-98-3p is overexpressed in all CR and LA diets and may affect
HAT and HDAC activity. a Heatmap of the 175 DE miRNAs across all diets and ages; created in R using the heatmap3 package. mir-98-3p is
highlighted by a green box. Red = up-regulated, and blue = down-regulated, log2 fold change reported for statistically significant DE genes. White
means no statistically significant change in expression. b qPCR confirmation of RNA-seq results, showing miR98-3p differential expression in all CR
and LA supplemented diets. Orange bars are RNA-seq log2 FC and blue bars are qPCR FC (corrected to provide the true FC in the sample by Ratio – 1
if the sample was up-regulated and by (–1/Ratio) + 1 for down-regulated samples). The horizontal dotted line represents the 1 FC cutoff. Errors bars
represent the standard error calculated for log2 FC as follows: (Standard error/Mean) × log2e. Snord96a, Snord95 and Snord68 were used as reference
genes. c The difference in HDAC and HAT activity was calculated as a ratio of the transfection (TF) control and then transformed into true FC
(by Ratio – 1 if the sample was up-regulated and by (–1/Ratio) + 1 for down-regulated samples). A cutoff of 1 FC was used, represented by
the dotted line. The figure shows that the miR-98-3p inhibitor significantly (p < 0.001, two-tailed t-test) decreases HAT activity when compared
with HDAC activity. A miR-98-3p mimic appears not to affect HDAC/HAT balance (no statistically significant difference). LA reduces HDAC
activity (p < 0.001) and the untreated cells show a slight increase in both HAT and HDAC activity, indicating that transfection might affect
HDAC and HAT activity but not HDAC/HAT balance (no statistically significant difference). The error bars represent the standard deviation.
Experiments were performed independently three times with n = 3 wells per treatment




AL and CR ageing
6 months AL versus 12 months AL 0
6 months AL versus 28 months AL 0
12 months AL versus 28 months AL 1
6 months CR versus 12 months CR 16
6 months CR versus 28 months CR 9
12 months CR versus 28 months CR 2
AL versus CR
6 months AL versus 6 months CR 4
12 months AL versus 12 months CR 6
28 months AL versus 28 months CR 6
LA supplementation
28 months AL versus 28 month AL + LA 3
28 months CR versus 28 months CR + LA 20
12 months AL versus 12 months AL + LA 5
Diet switching
28 months AL versus 28 months AL > CR 4
28 months AL versus 28 months AL + LA > CR 39
28 months AL versus 28 months CR > AL + LA 26
28 months AL versus 28 months CR > AL 14
28 months CR versus 28 months AL + LA > CR 5
28 months CR versus 28 months AL > CR 7
28 months CR versus 28 months CR > AL + LA 2
28 months CR versus 28 months CR > AL 6
Benjamini-Hochberg FDR <0.05; n = 6 per group; 527 miRNAs expressed
in total
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also be important, but possibly in a tissue- or protein-
specific fashion.
Diet-induced longevity effects: 137 genes are associated
with long-lived cohorts
We next wanted to define the gene expression changes
specific to increased longevity. By focusing on our dietary
groups with extended longevity (Table 1) we were able to
pinpoint “longevity genes” that are DE specifically in such
groups. We also took into account the effect of LA sup-
plementation regardless of the longevity effect, i.e., we
excluded genes showing the same trend in expression
in LA-fed groups with no increase in longevity. This
gave us a “longevity gene” list of 137 genes (Additional
file 8) which are changed when longevity is increased by
our different diets. These genes are enriched for mito-
chondrion, oxidative phosphorylation, AD (ES = 2.57, not
FDR significant) and neuron differentiation and develop-
ment (ES = 1.99, not FDR significant). We also identified
Gad1 and Grik2 as being longevity associated, linking
glutamate excitotoxicity to ageing and longevity. Re-
generation and repair related genes were also identified
(Swi5, Nrep and Smn1) in long-lived cohorts.
To further investigate and validate our “longevity genes”,
we mapped the orthologues of the rat genes to longevity-
associated networks from mouse, Drosophila and Cae-
norhabditis elegans (see “Materials and methods”).
Twenty-eight of our “longevity genes” were previously
identified longevity-associated genes (LAGs) or partners
of LAGs (Fig. 5; Additional file 9). The overlap with LAGs
and their partners supports the idea that we have identi-
fied genes which have a role in longevity (overlap signifi-
cantly higher than expected by chance; p = 8.37E − 03).
Moreover, some of our “longevity genes” were found in
multiple networks. For example, Pik3r1, which is involved
in insulin resistance and AD [43], is found in the mouse,
Drosophila and C. elegans networks, suggesting that it
could be an important conserved modulator of longevity.
NPM1, Ubr5, Nduf6, Cox4i1 and Cytochrome c oxidase
subunit Va are present in at least two of the networks,
suggesting that these could also be important conserved
modulators of longevity.
Discussion
Our RNA-seq studies of the rat cerebral cortex during
ageing and dietary manipulation of longevity provide in-
sights at various levels. The cerebral cortex in ageing
AL-fed rats is characterised by changes in synaptic density
and vesicle transport that possibly affect synaptic transmis-
sion with increasing age. This fits with observations in
humans of decreasing synaptic density after the age of 2–16
years, and a further decline between 74–90 years [44],
and with models of neurodegeneration suggesting that
age-related cognitive decline may be part of a continuum
of neurodegenerative pathologies. We have found that key
genes involved in DNA and histone methylation, tran-
scription and chromatin re-modelling (e.g. the histone H3
methyltransferase Dot1L, Tet3 and Chd5) are differentially
expressed with age in rats. In agreement with published
studies [45, 46], this suggests that ageing is characterised
by a global reduction in methylation, possibly driving the
gene expression changes observed. Importantly, these age-
related changes in gene expression are not observed with
ageing when the rats are maintained on a CR feeding
regime.
We show that a shared neuroprotective gene expres-
sion profile is induced by a CR feeding regime and also
by LA supplementation (when fed AL). This neuropro-
tective signature is characterised by an altered response
to oxidative stress. Glutathione (GSH) is an important
antioxidant, the metabolism of which is impaired in the
brain during anxiety, in memory impairment states, and
age-related neurodegeneration [34]. Glrx (a member of
the antioxidant system and up-regulated in this study) is
increased in AD brains and may be involved in beta-
amyloid toxicity [47]. Transgenic mice that overexpress
thioredoxin are more resistant to inflammation [48] and
show decreased mortality rates in the early part of the
(See figure on previous page.)
Fig. 4 Dietary memory effect approach and networks. a The red boxes represent diet groups that have no effect on longevity (baseline longevity)
and the green boxes represent diets that extend longevity. This shows how we compared the diet groups to identify the key genes involved in
the dietary memory effect. First the DE gene list for AL versus CR > AL + LA (“>” = switched), which results in extended longevity, was compared
with the DE gene lists for two conditions that do not result in extended longevity but do have a diet switch and LA supplementation, thereby
identifying the genes for extended longevity but excluding the confounding effect of LA supplementation and diet switching. Next, DE genes
from AL versus AL + LA > CR (baseline longevity) were compared with those from the extended longevity AL versus AL > CR condition, identifying
genes LA induces that are important in disrupting the longevity effect of switching to CR. Finally, the effect of the order of LA supplementation
(before or after diet switch) was identified. The three resulting lists were then compared to identify key genes involved in the dietary memory
effect of LA. b Simplified networks of related statistically significant enriched GO terms using the Cytoscape add-on ClueGO [30, 31]. The network
shows enrichment of gene function for the dietary memory effect genes (Additional file 6). The Cytoscape add-on ClueGO allows enrichment
analysis and the collapsing of GO terms into parent categories for each comparison. The filled coloured circles (nodes) represent each statistically
significant parent GO term. The lines (edges) between the nodes show that there are overlapping genes within each term. Each of the terms is
statistically significant (Benjamini-Hochberg correction <0.05). The different sizes of the nodes relates to how many genes fall into that term
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lifespan but maximal lifespan is not increased [49]. As
LA supplementation of the diet alone does not increase
longevity, it is unlikely that thioredoxins will increase
longevity. They are, however, likely to contribute to a
neuroprotective phenotype and it is interesting that we
found them to be overexpressed. This emphasises the
potential importance of anti-oxidant and diet research in
improving brain health in the elderly. We also observed
gene expression changes in glutamatergic activity with
age and diet. Changes in glutamatergic activity have
been observed previously in the rat hypothalamus and
hippocampus [50] and glutamate-dependent neuroglial
calcium signalling has been shown to differ between the
young and the adult brain [51]. To our knowledge, ours
is the first study to indicate that CR feeding and LA diet-
ary supplementation alter the glutamatergic response in
the rat cerebral cortex. It is of note that LA can potenti-
ate glutamate receptor activity and has been suggested
as a neuroprotective therapy option for AD and related
dementias [52–55].
In our work, we identified a number of differentially
expressed miRNAs with age and dietary intervention.
miRNAs are of interest because neuronal degeneration
has been linked to miRNA dysfunction in Drosophila
[56] and knock-out of DICER in the forebrain of adult
mice results in a neurodegenerative phenotype [57].
miRNAs are also involved in synaptic development and
plasticity in mammalian neurons [58] and have been
implicated in neurological conditions such as Parkinson’s
disease and AD [58]. One miRNA, miR-98-3p, showed
consistent overexpression in CR and LA supplementation
of the diet in our study. Using transfection and HAT and
HDAC assays, we demonstrated a potential role for this
miRNA in maintaining HDAC and HAT balance, thereby
contributing to a neuroprotective phenotype. The activity
of HDACs is altered in CR rats, suggesting that global dea-
cetylation may be important in ageing, longevity and neu-
roprotection [59, 60]. Also, LA exhibits HDAC inhibitor
activity even if this seems to be cell type-specific [61]. Our
data support previous findings indicating that epigenetic
modifications have a significant role to play in ageing and
dietary modulation of ageing.
Using our unique set of RNA-seq data we began to
unravel the dietary memory effect and gene expression
changes related to increased longevity of LA supplementa-
tion of the diet. We saw an enrichment for genes related to
Fig. 5 Overlap of longevity genes identified in the rat cerebral cortex with the longevity associated networks in mouse, Drosophila and C. elegans.
The 28 longevity genes identified in rats in this study were found to be longevity-associated genes (LAGs) or partners of LAGs in the longevity
networks for mouse, Drosophila and C. elegans (overlap significantly higher than expected by chance; p = 8.37E − 03, Fisher’s exact test). LAGs are
genes which result in noticeable changes in the ageing phenotype and/or lifespan. These are identified experimentally through knockout, mutation,
overexpression or RNA interference [76]. Longevity networks (previously described in detail [79]) are protein–protein interaction networks, include a
core of LAGs, depicted in green in the figure, and their first order protein-interacting partners, shown in light green. The size of the network for each
species is thus dependent on the protein–protein interaction data, but also on the number of LAGs available from the literature. All overlaps are higher
than expected by chance (though this is not always statistically significant), with the overlap being significantly higher for worm LAGs, network
partners of fly LAGs and network partners of mouse LAGs. Fisher’s exact test (one-tailed) p values for each of the overlaps are as follows: worm LAG p
value = 6.11E− 05, fly LAG p value = 0.55, mouse LAG p value = 0.35, p value for LAG partners in worm longevity network = 0.09, p value for LAG partners
in fly longevity network 0.027, p value for LAG partners in mouse longevity network = 0.034
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the insulin signalling pathway, which was first associated
with ageing and longevity in C. elegans [62] and is known
to modulate ageing from worms to mammals [63]. Phos-
phatidylinositols are part of the insulin signalling pathway
[64] and are also enriched in our results. Metabolism and
energy-related pathways, such as the tricarboxylic acid
cycle, are also enriched. It is interesting to note that the
tricarboxylic acid cycle is known to mediate the epigenetic
landscape of chromatin in cancer by regulating DNA and
histone methylation and it has been hypothesised that epi-
genetic changes with ageing could be due to an impaired
Kreb’s cycle [65].
Using existing data sets on LAGs, we found that 28
of our genes specifically DE in long-lived cohorts were
known LAGs. It should be noted that LAGs are identi-
fied through single gene manipulations (knockout or
overexpression), followed by lifespan studies. This shows
that some of the genes that can modulate lifespan, and
more importantly many of their protein–protein inter-
action partners, are differentially expressed in response to
CR feeding.
Conclusions
Additional studies are required to understand the role of
epigenetics and post-translational modifications in age-
ing and longevity. This study presents extensive data on
the effect of diet and ageing on the cerebral cortex tran-
scriptome, serving as a starting point for future investi-
gation into neuroprotection, longevity and dietary
intervention in ageing and age-related disease. It also
emphasises the importance of epigenetics and post-
translational modification in ageing and longevity, and
provides candidate genes for future studies.
Materials and methods
Diets
The non-supplemented CRM diet was supplied by Dietex
International, Witham, UK. The LA-supplemented diet
was the CRM diet enriched with a racemic mixture of DL-
thioctic acid (α-lipoic acid) obtained from Fisher Scientific
UK Ltd, at 1.5 g/kg by the Special Diet Systems Division
of Dietex International. LA is known to have an anti-
obesity effect by inhibiting food intake and retarding
growth [66]; therefore, in the previous study by Merry et
al. [10], it was ensured that the dose supplied to the ani-
mals did not inhibit the growth rate to induce an indirect
dietary restriction effect.
Animals
A previous experiment supplied the rat brain tissue
for this study [10]. All animal husbandry procedures
undertaken in this study were carried out in accordance
with the provisions of the United Kingdom Animals
(Scientific Procedures) Act 1986. The animal study from
which the tissue was generated for the current publication
was conducted under the Home Office Project Licence
40/2964, held by B.J.M. The work was also reviewed by
the University of Liverpool Ethical Committee for Animal
Welfare. Male BN rats (SubstrainBN/SsNOlaHSD) were
obtained from Harlan UK at 21–28 days of age and main-
tained under barrier conditions on a 12-h light:12-h dark
cycle (08:00–20:00). The health status of the rats was
monitored at regular intervals through the screening of
sentinel animals. All animals were caged in groups of
four and fed the non-supplemented CRM diet AL until
2 months of age, when they were transferred to single
housing and assigned randomly to one of six dietary
groups as summarised in Table 1. All rats fed AL and
CR were sacrificed at 6, 12, and 28 months of age. Animals
subjected to CR were fed either the CRM diet or the LA-
supplemented CRM diet at 55 % the daily food intake of
control rats to maintain their body weight at approxi-
mately 55 % that of age matched AL-fed animals. The diet
of animals maintained on a CR regime was supplied daily
as pre-weighed rations between 10:30 and 11:00 h. The
daily food ration supplied to CR animals was the same
for age-matched animals irrespective of whether they
were fed the CRM diet or the LA-supplemented CRM
diet. Six dietary feeding combinations were studied to
compare the effect of AL or CR feeding with and with-
out LA supplementation. Survival trajectories for these
groups were previously determined [10]. All groups were
run simultaneously and so experienced identical hus-
bandry and housing conditions. None of the animals
exhibited any signs of pathology when sacrificed. Each
age group had six rats from which tissue samples were
taken, flash frozen and stored at −80 °C.
Cortex dissection and RNA and miRNA extraction
To minimise thawing and therefore degradation of RNA,
the cerebral cortex was removed from the whole brain
on a solid CO2 base under a dissecting microscope. The
cerebral cortex was cut into small pieces to aid RNA
extraction.
RNA was extracted from the cerebral cortex using
Qiagen's TissueLyser II and RNeasy lipid tissue kit. The
quality of the extracted RNA was assessed using the Agi-
lent 2100 Bioanalyser; all RNA integrity numbers (RINs)
were above 8, indicating that good quality RNA had
been extracted. Each sample was split in two for either
whole transcriptome or small RNA analysis. For the
whole transcriptome analysis the samples were pooled
two by two (leaving three samples per age/diet group).
Ribosomal RNA was removed from the pooled samples
using a Eukaryote ribominus kit (Invitrogen) and con-
firmed with the Agilent 2100 Bioanalyser. Ribosomal
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removal, rather than poly(A) selection, allows certain
non-coding RNAs without poly(A) tails to be included
in the sequencing.
The miRNA fraction was enriched using the miRVana
kit. The enriched miRNA samples were then pooled as
with the whole transcriptome samples.
cDNA library preparation and SOLiD sequencing
The whole transciptome library preparation protocol was
carried out according to the manufacturer’s instructions.
The RNA was fragmented and cleaned up using spin col-
umns (Invitrogen) and SOLiD RNA adapters were then
hybridised and ligated to the samples. Reverse transcrip-
tion was performed to generate cDNA. The cDNA was
purified, size selected, amplified and then purified again
(as detailed in the SOLiD protocol). The size distribution
of the cDNA library was assessed using the Bioanalyser.
The samples were then subjected to emulsion PCR and
sequenced in the Centre for Genomic Research at the
University of Liverpool (https://www.liverpool.ac.uk/
genomic-research/) using the SOLiD system 5500xl to
generate 75-bp forward reads.
The miRNA library preparation protocol was carried
out according to the manufacturer’s instructions. The sam-
ples were then subjected to emulsion PCR and sequenced
in the Centre for Genomic Research at the University of
Liverpool using the SOLiD system v4 to generate 50-bp
forward reads.
Whole transcriptome data mapping and differential
expression analysis
The RNA-seq results from the SOLiD system were out-
put as colour space fasta and quality files, and these files
were mapped to the Ensembl release 71 rat reference
genome (Rnor_5.0, March 2012) using Bowtie (http://
bowtie-bio.sourceforge.net/index.shtml); the reads were
filtered by quality using the –e phred quality setting (-e
400), multiple mapping reads were not allowed and the
best option was used with mismatches limited to 2. For
each sample approximately 36 million reads were gener-
ated. On average, 23 million reads per sample were mapped
to the reference genome (approximately 63 % of reads
generated were mapped; this figure is relatively low be-
cause of the conservative options specified in Bowtie
but ensures that the highest quality and most robust
alignments are reported). All data have been submitted
to Gene Expression Omnibus (GEO) under the accession
GSE57110. The differential expression analysis was carried
out as in our previous study [14]. In brief, raw counts
per gene were estimated by the Python script HTSeq
count (http://www-huber.embl.de/users/anders/HTSeq/)
and used by EdgeR [67] to estimate DE in pair-wise com-
parisons. Counts per million (cpm) were calculated and
only genes with 1 cpm in at least three samples were
included in the analysis. Trimmed mean of M-values
(TMM) normalisation of the sequenced libraries was
performed to remove effects due to differences in library
size. EdgeR generates a FC for each gene; p values and the
Benjamin-Hochberg FDR were calculated to statistically
test the measured DE. As in previous studies, no effect of
size cutoff was used, as ageing-related changes tend to be
subtle [23].
Enrichment analysis and heatmap generation
To create heatmaps of DE genes, R and the R package
heatmap3 were used along with the log2 FC output from
EdgeR. To assess the biological significance of gene ex-
pression changes we used the Cytoscape plug-in ClueGO
to perform an enrichment analysis on each individual
comparison and then, using a built-in algorithm, the GO
terms were collapsed based on related terms and statis-
tical significance in order to give a simplified network
[68, 69]. Further enrichment analysis was performed by
GSEA [70, 71] and DAVID [72].
Whole transcriptome qPCR validation
To generate cDNA for qPCR, 3.5 μg of total RNA was
reverse transcribed using Superscript III First-strand
synthesis system for RT-PCR (Invitrogen, Paisley, UK).
The Roche Universal Probe Library was used to design
primers with sequences obtained from Ensembl. All
primers were designed to cross an exon–exon boundary.
The specificity of the primers was checked using BLAST
(http://blast.ncbi.nlm.nih.gov/Blast.cgi). A reference gene
experiment was conducted to identify the most stably
expressed genes in the cerebral cortex with age and
diet (data not shown); Hprt1 (Additional file 10), B2m
(Rn00560865_m1, Applied Biosystems) and Ywhaz
(Rn00755072_m1 Applied Biosystems) were the most
stably expressed in all conditions. The reference genes
were used to normalise the qPCR results. Additional
file 10 shows the primers, amplicons, and probes used.
The qPCR assays were all performed in triplicate using
a TaqMan™ ABI PRISM 7500 fast (Applied Biosystems,
Foster City, CA, USA) in 96-well plate format. A 20-ml
reaction volume was used per well, consisting of 10 μl
Taqman 2× PCR master mix (Universal PCR Mastermix,
Applied Biosystems), 0.2 μl each of 20 mM forward and
reverse primers, 0.2 μl of 10 mM probe (Exiqon, Roche
Diagnostics Ltd), 0.2 μl distilled water and 9.2 μl of cDNA
or water for the negative controls. The amplification was
performed as follows: 2 min at 50 °C, 10 min at 95 °C
followed by 40 cycles of 95 °C for 15 s and 60 °C for
1 min. The efficiency of the assays was between 93 % and
107 % and the R2 values were >0.98. The ΔΔcT method
was used to measure expression. The data were further
corrected by the efficiency of the standard curve for each
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gene. Log2 FC was calculated and compared with the
RNA-seq results in order to confirm the expression
results. The standard error was calculated for log2 FC
as follows: (Standard error/Mean) × log2e. For qPCR the
relative quantification value was used to calculate standard
error. For RNA-seq, raw reads converted into relative
values were used to calculate standard errors.
miRNA mapping
The RNA-seq results from the SOLiD system were output
as colour space fasta and quality files. Using a custom script
the base space adapter sequences was converted into colour
space. A freely available Python script (cutadapt; https://
cutadapt.readthedocs.org/en/stable/) was used to remove
the adapter sequence and output a cfastq file. The
freely available stand-alone Java program miRanalyzer
[73] was used for mapping and analysis (http://bioinfo2.u-
gr.es/miRanalyzer/standalone.html). Using the Perl scripts
provided by miRanalyzer, the reads were grouped and then
mapped using Bowtie. miRanalyzer maps to a Bowtie index
file for the rat; it then removes reads mapping to RefSeq
(known mRNA) and Rfam (other known non-coding
RNAs), leaving the user with reads that are likely to be
miRNAs. New novel miRNAs are identified by miRanaly-
zer, detailing the secondary structure and number of times
predicted by the five algorithms it uses. The results are also
split into files for uniquely mapping and ambiguously map-
ping reads. This results in very clean results which are
uniquely mapped.
miRNA differential expression analysis
The differential expression analysis was carried out using
a range of custom Python scripts, conditional quantile
normalisation [74] and EdgeR. Conditional quantile nor-
malisation and Lowess normalisation have been shown
to be most appropriate for miRNA analysis [75]. The
known miRNAs were analysed separately from the novel
predictions. Only reads with one count per million in at
least three samples were included in the analysis. After
normalisation and exclusion of low read counts, the differ-
ential expression analysis was carried out using EdgeR’s
generalised linear model and tag-wise dispersion. A FDR
cutoff of 0.05 was used.
miRNA qPCR
Validation of the miRNA differential expression results
was carried out using the miScript PCR system (Qiagen).
Reverse transcription using the miScript II RT kit was
carried out according to the manufacturer’s instructions:
4 μl 5× miScript HiSpec buffer, 2 μl 10× miScript
nucleics mix, 2 μl miScript reverse transcriptase mix into
a total volume of 20 μl with 10 ng to 2 μg of template
miRNA. This was incubated for 60 min at 37 °C and then
5 min at 95 °C. The resulting cDNA was diluted by adding
200 μl of distilled water. The miScript SYBR Green PCR
Kit was used for the qPCR reaction. All samples were per-
formed in triplicate in a 96-well plate format, using 2.5 μl
cDNA, 12.5 μl 2× quantiTECT SYBR, 2.5 μl 10× miScript
universal primers, 2.5 μl miScript primer assay, 5 μl RNase
free water per well. Six small nucleolar RNAs (snoRNAs)
provided and validated by Qiagen were used as the refer-
ence genes. Subsequently, a reference gene stability experi-
ment ascertained that only three reference genes were
required (Snord96a, Snord95 and Snord68).
LAG analysis
The comparison with known mouse, fly and worm LAGs
was done using data from the Human Ageing Genomics
Resources GenAge database, using build 16 [76]. Protein–
protein interaction data for the construction of longevity
networks and for the analysis of LAG partners were re-
trieved from the BioGRID database [77, 78], release 3.1.83.
The construction of longevity networks has been de-
scribed in detail previously [79]. Briefly, the networks in-
clude LAGs as a core set, and their first order interaction
partners. Only the largest connected component is kept in
the network.
In order to compare the rat “longevity genes” with genes
from other species, orthologs were obtained using the
InParanoid7 database [80]. Exclusion of inparalogs was
done for the default threshold score of 0.05.
Cell culture
CTX TNA2 cells were purchased from HPA cultures (UK).
The cells were maintained in DMEM (Life Tech) with high
glucose, L-glutamine, phenol red, sodium pyruvate. The
DMEM was supplemented with 10 % foetal bovine serum
and penicillin-streptomycin-glutamine. The cells were
sub-cultured three times a week. Passages 12–14 were
used for the experiments.
Transfection
The confluent cells were sub-cultured and diluted 1 in
10 in antibiotic-free media and then counted using a
haemocytometer. The cells were diluted to 1 × 104 and
100 μl of cell solution was added to each well of a 96-
well plate. The cells were incubated overnight at 37 °C,
5 % CO2 to allow them to attach. The transfection was
performed using the Dharmacon miRNA system. Mimics
and inhibitors for miR-98-3p, positive controls, including a
miRNA mimic that inhibits GAPDH and a miRNA mimic
that increases miR-16, and two negative controls (mimic
and inhibitor) were used to assess the transfection efficiency
and viability by comparing with a transfection reagent-only
control and an untreated control. The viability was assessed
using the Alamar Blue assay and by 96 hours the mimic
was at 115 % viability compared with the transfection con-
trol, and the inhibitor was at 86 % viability compared with
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the transfection control (see Additional file 11 for results).
The mRNA was extracted using the cells-to-CT kit
(Life Tech) according to the manufacturer’s protocol. The
miRNA was extracted using the miRvana kit as above.
cDNA synthesis and qPCR were performed as above using
Actb as the reference gene for the mRNA experiment.
The transfection efficiency was ascertained by qPCR by
measuring GAPDH and miR-16 knock down. GAPDH
was reduced 4.2-fold and miR-16 was reduced 5.75-fold
(see Additional file 11 for qPCR results).
Nuclear extraction from cells and HAT and HDAC activity
assay
The EpiQuik Nuclear Extraction Kit was used according
to the manufacturer’s instructions to extract the nuclear
proteins from transfected cells.
The Epigenase HDAC activity direct assay kit and the
EpiQuik HAT activity kit (Cambridge Biosciences) were
used to assess HAT and HDAC activity in transfected cells.
The kit is an antibody-based assay with a colourmetric
readout, assessed by the Multiskan microplate reader at
450 nm.
Western blotting
Frozen liver tissue was defrosted and homogenised in an
approximately equal volume of protein extraction buffer
(50 mM Tris-HCl, pH 6.8, 86 nM 2-mercaptoethanol,
2 % sodium dodecyl sulfate (SDS) and general protease
inhibitors (cocktail, Sigma, category no. P8340), centri-
fuged at 13,000 rpm for 15 min and the supernatant
containing the soluble protein collected. The protein
concentration of the supernatant was determined using
a bicinchoninic acid assay according to the supplier's
protocol (Abcam, Sigma) adapted to a 96-well plate for-
mat. Absorbance at 562 nm was measured and protein
concentrations were back-calculated from the standard
curve using the SpectroMax software (Molecular Dy-
namics). Samples were diluted to 5 mg protein ml−1.
SDS PAGE was carried out on a large BIO-RAD kit
using a 7.5 % or 12 % SDS-polyacrylamide gel and con-
taining 1.5 M Tris-HCl (pH 8.8). Two SDS-PAGE runs
were carried out simultaneously in a standard 0.1 %
SDS, Tris-Glycine running buffer. The mini gels were
electrophoresed overnight at 45 V. Proteins were then
transferred at 350 mA (4 hours) in transfer buffer (20 %
methanol, Tris-Glycine buffer) onto a nitrocellulose
membrane (Amersham Hybond ECL). Membranes were
blocked with 5 % dried skimmed milk (Marvel) dissolved
in Tris-buffered saline (TBS; pH 8.8). Membranes were
then washed twice for 10 min in changes of TBS before
being incubated for 1 hour with a 1/5000 dilution of
mouse anti-acetylated lysine antibody (Ac-K-103, Cell
Signalling Technologies). Membranes were incubated
with the secondary horseradish peroxidise-conjugated
anti-mouse antibody (Amersham ECL) at a 1/10,000
dilution in blocking solution (50 ml per membrane)
for 1–2 hours. Visualisation of the protein bands was
by enhanced chemiluminescence (ECL). The gels were
stripped and re-probed with beta actin as a loading gel
control.
The developed films were analysed using ChemiImager
v4.4 software to give an arbitrary quantitative value to
allow comparison of band intensity. This was adjusted to
account for background, area and absolute protein con-
centration (by normalising to the loading gel control
intensity).
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